Stay updated on Sabatolimab & Magrolimab Treatment in AML Clinical Trial

Sign up to get notified when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T12:50:18.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A sitewide notice explains that federal agencies are transitioning from using “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-26T16:31:05.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T21:38:27.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-13T04:16:06.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) was added to the study record history, replacing the previous revision (v3.6.6).
    Difference
    0.1%
    Check dated 2026-09-21T22:04:55.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The record history adds a new revision entry v3.6.6, and the previous revision v3.6.5 is removed. This represents a minor metadata update to the study record.
    Difference
    0.1%
    Check dated 2026-08-31T17:44:47.000Z thumbnail image

Stay in the know with updates to Sabatolimab & Magrolimab Treatment in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.